To evaluate therapeutic potential, spheroids were treated with A‐1331852, a selective Bcl‐xL inhibitor known to induce apoptosis in senescent cells in PSC and PBC mouse models Drug efficacy was measured by apoptosis induction, reduction of fibrosis, and modulation of stromal activation. Here, BCL2L1 is linked to primary biliary cholangitis.